Kurfürstliches Schloss: Peter-Altmeier-Allee 9, 55116 Mainz, Germany
Google MapsKurfürstliche Schloss: Peter-Altmeier-Allee 9, 55116 Mainz, Germany
Google MapsMD, PhD. Professor Surgery
University of Granada, Spain.
Juan Ignacio Arcelus is Professor of Surgery at the University of Granada, and General and Digestive Surgeon at the Virgen de las Nieves University Hospital in Granada. He is actively involved in several scientific societies, including the Spanish Association of Surgeons (AEC), the Royal Academy of Medicine of Granada, the Spanish Foundation for the study of VTE, and is a member of the RIETE registry. His research primarily focuses on venous thromboembolic disease, with numerous publications and contributions to guidelines for patient care, particularly in perioperative management and oncology, such as ACCP, ASCO, ITAC and others.
MD, PhD. Head of Department of Anaesthesiology, Resuscitation and Pain Therapy
University Hospital Doctor Peset,
Valencia,Spain.
Juan Vicente Llau is Head of the Anesthesiology-Reanimation and Pain Therapy Service and Coordinator of the Surgical Block at the University Hospital Doctor Peset in Valencia. Additionally, he serves as an Associate Professor of Anesthesiology in the Department of Surgery at the University of Valencia. With a focus on hemostasis and anesthesiology, he actively contributes to various scientific societies, including serving as an Associate Editor for several journals. He has been involved in numerous task forces and committees addressing topics such as massive bleeding, perioperative thromboprophylaxis, and the interaction between antithrombotic drugs and regional anesthesia.
Dr. Ingrid Pabinger
Professor of the Department of Medicine I, Clinical Division of Haematology and Haemostaseology, Medical University of Vienna, Austria.
Read moreDr. Cecilia Becattini
Professor of Internal Medicine at the University of Perugia, Internal and Cardiovascular Medicine and Stroke-Unit of the University Hospital in Perugia, Italy.
Read moreProfessor of the Department of Medicine I, Clinical Division of Haematology and Haemostaseology, Medical University of Vienna, Austria.
Ingrid Pabinger is Professor at the Clinical Division of Haematology and Haemostaseology, Department of Medicine I, at the Medical University of Vienna. Her scientific fields of expertise encompass hereditary and acquired bleeding disorders, including hemophilia, and thrombotic disorders. She has published more than 530 papers and has acted as principal investigator of numerous clinical studies in bleeding and thrombotic disorders as well as immune thrombocytopenia. She has been involved in several international scientific societies, such as the ISTH, ASH, ETHA, GTH, EHA, as member, chair or president.
Professor of Internal Medicine at the University of Perugia, Internal and Cardiovascular Medicine and Stroke-Unit of the University Hospital in Perugia, Italy.
Cecilia Becattini is Professor of Internal Medicine at the University of Perugia and works at the Internal and Cardiovascular Medicine and Stroke-Unit of the University Hospital in Perugia, Italy. Her research is focused on the field of prevention, diagnosis and treatment of venous thromboembolism and atrial fibrillation, having authored more than 250 scientific publications in international peer reviewed journals. In addition, she is editor in some journals, and she is an active member of the ESC, participating in task forces for pulmonary embolism and circulation.
Dr. Nikolaos Tsoukalas
Director of the Oncology Department. 401 General Military Hospital, Athens, Greece
Read moreDr. Karen Schreiber
Rheumatologist, Danish Hospital for Rheumatic Diseases, Sønderborg, Denmark
Read moreInternist, NoordWest Ziekenhuisgroep, Alkmaar, Netherlands
Ingrid Bistervels started working as a medical doctor at the Department of Internal Medicine at the Flevo Hospital in Almere. She has worked with Saskia Middeldorp in Amsterdam, where she had the Highlow study as her main project. She then moved on to work with Ander Cohen in the Guys and St. Thomas’ Hospital, focusing on long-term outcomes of venous thromboembolism. She currently works as a Resident in Internal Medicine at the NoordWest Ziekenhuisgroep in Alkmaar and is excited to further integrate cutting-edge research in the field of pregnancy-related thrombosis with her clinical work.
Director of the Oncology Department. 401 General Military Hospital, Athens, Greece.
Nikolaos Tsoukalas is a medical oncologist and Director of the Oncology Department of 401 General Military Hospital of Athens, as well as a Consultant at Henry Dunant Hospital Center in Athens. He is primary or sub-investigator in phase II and III clinical trials for different tumors and participates in some observational studies and registries regarding cancer associated thrombosis, among other topics. He is involved in the board of directors of HeSMO, and Scientific Director of the Hellenic Academy in Oncology,
Rheumatologist, Danish Hospital for Rheumatic Diseases, Sønderborg, Denmark
Karen Schreiber is a Rheumatologist at the Danish Hospital for Rheumatic Diseases in Søndeborg and Associate Professor at the Institute for Health Research in Southern Denmark, Odense University. Her clinical and research focusses are improving reproductive health care for patients with rheumatic diseases. Her main passion is the pathophysiology and treatment of thrombotic and obstetric antiphospholipid syndrome. She is a member of EULAR (where she co-leads the Reproductive Healthcare and Family Planning group), BSR (where she is founding member of the pregnancy group) and of the Danish Society for Rheumatic Diseases.
18:30 -19:00 Registration
19:00-19:05 Opening ceremony Speaker: ROVI representative
19:05-19:15 Welcome reception Speakers: Dr. Juan I. Arcelus and Dr. Juan V. Llau
19:15-20:00 Evolution in the impact of VTE Speaker: Dr. Juan I. Arcelus
20:00-22:00 Welcome dinner
9:00-10:00 Registration
10:00-10:15 Welcome Speaker: Dr. Juan I. Arcelus and Dr. Juan V. Llau
10:15-10:40 Factors influencing cancer-associated thrombosis
10:40-10:50 Q&A
10:40-10:50 Perinatal thrombosis: identifying high-risk patients and preventative measures Speaker: Dr. Juan I. Arcelus and Dr. Juan V. Llau
11:15-11:25 Q&A
11:25-11:55 Coffee Break
11:55-12:25 Pros & Cons: Is it necessary to monitor anti-Xa levels in specific populations receiving LMWHs? Speakers: Drs. Ingrid Pabinger & Ingrid Bistervels
12:25-12:35 Q&A
12:35-13:05 Pros & Cons: DVT and PE, does one treatment fit both? Speakers: Dr. Nikolaos Tsoukalas & Speaker to be confirmed
13:05-13:15 Q&A
13:15-14:45 Lunch Break
14:45-15:15 Pros & Cons: Surgical thromboprophylaxis: LMWHs or DOACs? Speakers: Dr. Juan I. Arcelus & Juan V. Llau
15:15-15:25 Q&A
15:25-15:55 VTE in patients with autoimmune diseases Speaker: Dr. Karen Schreiber
15:55-16:05 Q&A
16:05-17:05 Clinical cases workshops Speakers: Dr. Nikolaos Tsoukalas & Speaker to be confirmed
17:05-17:15 Concluding remarks. Speakers: Juan Vicente Llau & Juan Arcelus